MedTrace Logo

Comparing Cobalt-Chromium Versus PEEK Secondary Telescopic Crowns on Implant Retained Mandibular Overdenture.

NCT06637930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-10-16

No results posted yet for this study

Summary

The aim of this randomized clinical trial was to compare

I- The clinical behavior of implant retained removable overdenture using telescopic retention system fabricated using CAD\\CAM techniques where the effects of the different material combinations were examined in regard to:

1. Retention of the mandibular over-denture.
2. Plaque accumulation, presence of calculus, bleeding tendency, health of peri-implant mucosa and probing depth.

II - The radiographic behavior regarding marginal bone level and bone density.

Conditions

  • Edentulism

Interventions

OTHER

Edentulous Alveolar Ridge In Mandible

implant retained mandibular overdenture using telescopic attachment system. all the patients received 2 implants at the canine region bilaterally using sterelithographic guide , then healing period for 3 months for proper osseointegration , then digital intraoral scanning was performed to detect implant position using scannable bodies , abutments which act as primary crowns were designed on cad software then milled using premilled titanium abutments.the study grouping was performed then virtual model was done for the designing of the frameworks then milled according to the grouping of the study. Try in of the frameworks was done and overdentures were inserted. * Retention force test was done using digital force gauge. * Probing depth using Teflon coated periodontal probe. * Marginal bone level and bone density were measured using digital periapical x-ray

Sponsors & Collaborators

  • Amr El Sayed Khalifa

    lead OTHER

Principal Investigators

  • Emad TB Agamy, Professor of Prosthodontics · Faculty of Dentistry, Minia university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
52 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2023-11-30
Completion
2024-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06637930 on ClinicalTrials.gov